European Markets for Clot Management Devices 2009

This publication has been discontinued on October 26, 2011.

Below is the updated product.

Introduction

Abstract

This report covers France, Germany, Italy, and the UK.

Methodology

Research Methodology

The following report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include:

• Government Sources:
  • Securities and Exchange Commission filings
  • Food and Drug Administration and patent filings
  • National Center for Health Statistics data
• Clot Management Device Companies:
  • Annual reports, product brochures, corporate profiles, etc.
• Internal Databases and Reports:
  • Previous reports on similar/related sources
• General Internet Searches, Medical Literature, and Newspaper/Magazine Searches:
  • Identifying various centers of specialization and articles that might provide leads for primary research.

The secondary research stage builds the foundation for the primary research.

The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is, thus, either discarded or marked as high or low priority. It is then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various clot management device market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes [units and US$] and market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research, industry and medical experts are identified. These experts are now contacted by telephone and asked to participate in interviews on recent trends and developments in the industry.

Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of the particular interviewee, although in most cases, the most important questions are asked of all experts. The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then either augmented, discarded, or adjusted, based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and reach positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 EUROPEAN CLOT MANAGEMENT DEVICE MARKET

• 1.1 Market Overview
• 1.2 Disease Overview
  • 1.2.1 Thrombosis
• 1.3 Indication Overview
  • 1.3.1 Arteriovenous Access Thrombosis
  • 1.3.2 Deep Vein Thrombosis
    • 1.3.2.1 Post-Thrombotic Syndrome
  • 1.3.3 Peripheral Artery Thrombosis
  • 1.3.4 Venous Thromboembolism
  • 1.3.5 Coronary Thrombosis
  • 1.3.6 Acute Ischemic Stroke
• 1.4 Market Analysis
  • 1.4.1 Economic Assumptions for the Forecast Period
  • 1.4.2 Procedures by Type
    • 1.4.2.1 Thrombectomies
      • Percutaneous Thrombectomies
      • Surgical Thrombectomies
    • 1.4.2.2 Inferior Vena Cava Filter Placement
    • 1.4.2.3 Catheter-Directed Thrombolysis
    • 1.4.2.4 Neurovascular Embolectomies
  • 1.4.3 Procedures by Indication
    • 1.4.3.1 Arteriovenous Clot Management Procedures
    • 1.4.3.2 Venous Clot Management Procedures
    • 1.4.3.3 Peripheral Artery Clot Management Procedures
    • 1.4.3.4 Coronary Clot Management Procedures
    • 1.4.3.5 Neurovascular Clot Management Procedures
  • 1.4.4 Market Forecast
  • 1.4.5 Market Drivers and Limiters
• 1.5 Competitive Analysis
  • 1.5.1 Market Shares

2.0 THROMBECTOMY DEVICE MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Procedures
    • 2.2.1.1 Percutaneous Thrombectomy
    • 2.2.1.2 Surgical Thrombectomy
  • 2.2.2 Procedures, by Device Type
    • 2.2.2.1 Mechanical Thrombectomy
    • 2.2.2.2 Clot Aspiration Procedures
    • 2.2.2.3 Pharmacomechanical Thrombectomy
    • 2.2.2.4 Balloon Embolectomy
  • 2.2.3 Key Clinical Trial Summaries
  • 2.2.4 Market Forecast
    • 2.2.4.1 Mechanical Thrombectomy Catheter Market
    • 2.2.4.2 Aspiration Catheter Market
    • 2.2.4.3 Embolectomy Balloon Catheter Market
    • 2.2.4.4 Pharmacomechanical Thrombectomy Device Market
  • 2.2.5 Market Drivers and Limiters
• 2.3 Competitive Analysis
  • 2.3.1 Competitive Landscape
  • 2.3.2 Market Shares
  • 2.3.3 Competitor Discussions (in Alphabetical Order)
    • Arrow International (a Teleflex Medical Company)
    • Bacchus Vascular
    • Edwards Lifesciences
    • EKOS
    • ev3
    • IDev Technologies
    • Invatec
    • MEDRAD Interventional/Possis Medical
    • Medtronic
    • OmniSonics Medical Technologies
    • Spectranetics/Kensey Nash
    • Straub Medical
    • Vascular Solutions
    • Other

3.0 THROMBOLYTIC INFUSION CATHETER MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Thrombolytic Agents
    • 3.2.1.1 Recombinant Tissue Plasminogen Activator
  • 3.2.2 Procedures
    • 3.2.2.1 Catheter-Directed Thrombolysis
  • 3.2.3 Procedures by Indication
    • 3.2.3.1 Arteriovenous Catheter-Directed Thrombolysis Procedures
    • 3.2.3.2 Venous Catheter-Directed Thrombolysis Procedures
    • 3.2.3.3 Peripheral Artery Catheter-Directed Thrombolysis Procedures
    • 3.2.3.4 Coronary Catheter-Directed Thrombolysis Procedures
    • 3.2.3.5 Neurovascular Catheter-Directed Thrombolysis Procedures
      • Intravenous Thrombolysis in Acute Ischemic Stroke
      • Intra-Arterial Thrombolysis in Acute Ischemic Stroke
      • Combination Thrombolysis in Stroke: Intravenous/Intra-Arterial Recombinant Tissue Plasminogen Activator
  • 3.2.4 Key Clinical Trial Summaries
  • 3.2.5 Market Forecast
  • 3.2.6 Market Drivers and Limiters
• 3.3 Competitive Analysis
  • 3.3.1 Competitive Landscape
  • 3.3.2 Market Shares
  • 3.3.3 Competitor Discussions (in Alphabetical Order)
    • AngioDynamics
    • Boston Scientific
    • Cook Medical
    • ev3
    • Merit Medical Systems
    • Other

4.0 INFERIOR VENA CAVA FILTER MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Procedures
  • 4.2.2 Market Forecast
  • 4.2.3 Market Drivers and Limiters
• 4.3 Competitive Analysis
  • 4.3.1 Competitive Landscape
  • 4.3.2 Market Shares
  • 4.3.3 Competitor Discussions (in Alphabetical Order)
    • ALN
    • B. Braun
    • Boston Scientific
    • Cook Medical
    • Cordis
    • C. R. Bard

5.0 NEUROVASCULAR EMBOLECTOMY DEVICE MARKET

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Stroke Overview
  • 5.2.2 Treatment of Acute Ischemic Stroke
  • 5.2.3 Stroke Treatment in Europe
    • 5.2.3.1 France
    • 5.2.3.2 Germany
    • 5.2.3.3 Italy
    • 5.2.3.4 UK
  • 5.2.4 Market Definitions
    • 5.2.4.1 Mechanical Embolectomy Devices
  • 5.2.5 Procedures
  • 5.2.6 Market Forecast
  • 5.2.7 Market Drivers and Limiters
• 5.3 Competitive Analysis
  • 5.3.1 Competitive Landscape
  • 5.3.2 Market Shares
  • 5.3.3 Competitor Discussions (in Alphabetical Order)
    • BALT Extrusion
    • Concentric Medical
    • Penumbra
    • Phenox
    • Other

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL EXHIBITS

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit 1: Clot Management Device Market, by Country, Europe (US$), 2007 - 2013
• Exhibit 2: Thrombectomy Device Market, by Device Type, as a % of Total, Europe, 2008
• Exhibit 3: Thrombolytic Infusion Catheter Market, Europe (US$), 2007 - 2013
• Exhibit 4: IVCF Placements, by Device Type, as a % of Total, Europe, 2007 - 2013
• Exhibit 5: Neurovascular Embolectomy Device Market, Europe (US$), 2007 - 2013
• Exhibit 6: Leading Competitors in the Clot Management Device Market, Europe, 2008

METHODOLOGY

• Exhibit 7: Currency Exchange Rates, 2008

CHAPTER 1: EUROPEAN CLOT MANAGEMENT DEVICE MARKET

• Exhibit 8: Clot Management Device Market, Europe (US$), 2007 - 2013 (Graphical Format)
• Exhibit 9: Clot Management Procedures, by Segment, Europe, 2007 - 2013 (Graphical Format)
• Exhibit 10: Clot Management Procedures, by Segment, Europe, 2007 - 2013 (Tabular Format)
• Exhibit 11: Total Clot Management Procedures, by Indication, Europe, 2007 - 2013 (Graphical Format)
• Exhibit 12: Total Clot Management Procedures, by Indication, Europe, 2007 - 2013 (Tabular Format)
• Exhibit 13: Arteriovenous Clot Management Procedures, by Type, Europe, 2007 - 2013
• Exhibit 14: Venous Clot Management Procedures, by Type, Europe, 2007 - 2013
• Exhibit 15: Peripheral Artery Clot Management Procedures, by Type, Europe, 2007 - 2013
• Exhibit 16: Coronary Clot Management Procedures, by Type, Europe, 2007 - 2013
• Exhibit 17: Neurovascular Clot Management Procedures, by Type, Europe, 2007 - 2013
• Exhibit 18: Clot Management Device Market, by Device Type, Europe (US$), 2007 - 2013
• Exhibit 19: Clot Management Device Market, by Country, Europe (US$, € , and £), 2007 - 2013
• Exhibit 20: Clot Management Device Market, by Device Type, Europe (US$), 2007 - 2013
• Exhibit 21: Clot Management Device Market, by Device Type, Europe (€ ), 2007 - 2013
• Exhibit 22: Clot Management Device Market Growth, by Device Type, Europe, 2008 - 2013
• Exhibit 23: Clot Management Device Market, by Device Type, as a % of Total, Europe, 2007 - 2013
• Exhibit 24: Drivers of the Clot Management Device Market, Europe
• Exhibit 25: Limiters of the Clot Management Device Market, Europe
• Exhibit 26: Leading Competitors in the Clot Management Device Market, by Segment, as a % of Total, Europe, 2008
• Exhibit 27: Leading Competitors in the Clot Management Device Market, by Country, as a % of Total, Europe, 2008

CHAPTER 2: THROMBECTOMY DEVICE MARKET

• Exhibit 28: Thrombectomy Device Market, Europe (US$), 2007 - 2013 (Graphical Format)
• Exhibit 29: Thrombectomies, by Indication, Europe, 2007 - 2013 (Graphical Format)
• Exhibit 30: Thrombectomies, by Indication, Europe, 2007 - 2013 (Tabular Format)
• Exhibit 31: PV Thrombectomies, by Indication and Country, Europe, 2007 - 2013
• Exhibit 32: PV Thrombectomy Growth, by Indication and Country, Europe, 2008 - 2013
• Exhibit 33: PV Thrombectomies, by Indication and Country, as a % of Total, Europe, 2007 - 2013
• Exhibit 34: PV Thrombectomies, by Type and Country, Europe, 2007 - 2013
• Exhibit 35: PV Thrombectomy Growth, by Type and Country, Europe, 2008 - 2013
• Exhibit 36: PV Thrombectomies, by Country and Type, as a % of Total, Europe, 2007 - 2013
• Exhibit 37: AV Thrombectomies, by Type and Country, Europe, 2007 - 2013
• Exhibit 38: AV Thrombectomy Growth, by Type and Country, Europe, 2008 - 2013
• Exhibit 39: Peripheral Artery Thrombectomies, by Type and Country, Europe, 2007 - 2013
• Exhibit 40: Peripheral Artery Thrombectomy Growth, by Type and Country, Europe, 2008 - 2013
• Exhibit 41: Venous Thrombectomies, by Type and Country, Europe, 2007 - 2013
• Exhibit 42: Venous Thrombectomy Growth, by Type and Country, Europe, 2008 - 2013
• Exhibit 43: Coronary Thrombectomies, by Type and Country, Europe, 2007 - 2013
• Exhibit 44: Coronary Thrombectomy Growth, by Type and Country, Europe, 2008 - 2013
• Exhibit 45: Coronary Thrombectomies, by Country and Type, as a % of Total, Europe, 2007 - 2013
• Exhibit 46: ATTRACT Clinical Trial Summary, 2009
• Exhibit 47: TAPAS Clinical Trial Summary, 2009
• Exhibit 48: Thrombectomy Device Market, by Device Type, Europe (US$), 2007 - 2013 (Graphical Format)
• Exhibit 49: Thrombectomy Device Market, by Indication, Europe (US$ and € ), 2007 - 2013
• Exhibit 50: Thrombectomy Device Market, by Country, Europe (US$, € , and £), 2007 - 2013
• Exhibit 51: Thrombectomy Device Market, by Device Type, Europe (US$), 2007 - 2013
• Exhibit 52: Thrombectomy Device Market, by Device Type, Europe (€ ), 2007 - 2013
• Exhibit 53: Thrombectomy Device Market Growth, by Device Type, Europe, 2008 - 2013
• Exhibit 54: Thrombectomy Device Market, by Device Type, as a % of Total, Europe, 2007 - 2013
• Exhibit 55: PV Thrombectomy Device Market, by Device Type, Europe (US$), 2007 - 2013
• Exhibit 56: PV Thrombectomy Device Market, by Device Type, Europe (€ ), 2007 - 2013
• Exhibit 57: PV Thrombectomy Device Market Growth, by Device Type, Europe, 2008 - 2013
• Exhibit 58: PV Thrombectomy Device Market, by Device Type, as a % of Total, Europe, 2007 - 2013
• Exhibit 59: Coronary Thrombectomy Device Market, by Device Type, Europe (US$), 2007 - 2013
• Exhibit 60: Coronary Thrombectomy Device Market, by Device Type, Europe (€ ), 2007 - 2013
• Exhibit 61: Coronary Thrombectomy Device Market Growth, by Device Type, Europe, 2008 - 2013
• Exhibit 62: Coronary Thrombectomy Device Market, by Device Type, as a % of Total, Europe, 2007 - 2013
• Exhibit 63: Total Mechanical Thrombectomy Catheter Market, by Country, Europe (US$), 2007 - 2013
• Exhibit 64: Total Mechanical Thrombectomy Catheter Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 65: Total Mechanical Thrombectomy Catheter Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 66: PV Mechanical Thrombectomy Catheter Market, by Country, Europe (US$), 2007 - 2013
• Exhibit 67: PV Mechanical Thrombectomy Catheter Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 68: PV Mechanical Thrombectomy Catheter Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 69: Coronary Mechanical Thrombectomy Catheter Market, by Country, Europe (US$), 2007 - 2013
• Exhibit 70: Coronary Mechanical Thrombectomy Catheter Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 71: Coronary Mechanical Thrombectomy Catheter Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 72: Total Aspiration Catheter Market, by Country, Europe (US$), 2007 - 2013
• Exhibit 73: Total Aspiration Catheter Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 74: Total Aspiration Catheter Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 75: PV Aspiration Catheter Market, by Country, Europe (US$), 2007 - 2013
• Exhibit 76: PV Aspiration Catheter Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 77: PV Aspiration Catheter Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 78: Coronary Aspiration Catheter Market, by Country, Europe (US$), 2007 - 2013
• Exhibit 79: Coronary Aspiration Catheter Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 80: Coronary Aspiration Catheter Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 81: Embolectomy Balloon Catheter Market, by Country, Europe (US$), 2007 - 2013
• Exhibit 82: Embolectomy Balloon Catheter Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 83: Embolectomy Balloon Catheter Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 84: Pharmacomechanical Thrombectomy Device Market, by Country, Europe (US$), 2007 - 2013
• Exhibit 85: Pharmacomechanical Thrombectomy Device Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 86: Pharmacomechanical Thrombectomy Device Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 87: Drivers of the Thrombectomy Device Market, Europe
• Exhibit 88: Limiters of the Thrombectomy Device Market, Europe
• Exhibit 89: Leading Competitors in the Thrombectomy Device Market, by Country, as a % of Total, Europe, 2008
• Exhibit 90: Leading Competitors in the Thrombectomy Device Market, by Device Type, as a % of Total, Europe, 2008

CHAPTER 3: THROMBOLYTIC INFUSION CATHETER MARKET

• Exhibit 91: Thrombolytic Infusion Catheter Market, by Country, Europe (US$), 2007 - 2013 (Graphical Format)
• Exhibit 92: CDT Procedures, by Indication, Europe, as a % of Total, 2007 - 2013 (Graphical Format)
• Exhibit 93: CDT Procedures, by Indication, Europe, 2007 - 2013 (Tabular Format)
• Exhibit 94: CDT Procedures, by Indication and Country, Europe, 2007 - 2013
• Exhibit 95: CDT Procedure Growth, by Indication and Country, Europe, 2008 - 2013
• Exhibit 96: CaVenT Clinical Trial Summary, 2009
• Exhibit 97: IMS III Clinical Trial Summary, 2009
• Exhibit 98: SYNTHESIS EXP Clinical Trial Summary, 2009
• Exhibit 99: Thrombolytic Infusion Catheter Sales, by Country, Europe, 2007 - 2013
• Exhibit 100: Thrombolytic Infusion Catheter Market, by Country, Europe (US$), 2007 - 2013 (Tabular Format)
• Exhibit 101: Thrombolytic Infusion Catheter Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 102: Thrombolytic Infusion Catheter Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 103: Drivers of the Thrombolytic Infusion Catheter Market, Europe
• Exhibit 104: Limiters of the Thrombolytic Infusion Catheter Market, Europe
• Exhibit 105: Leading Competitors in the Thrombolytic Infusion Catheter Market, as a % of Total, Europe, 2008

CHAPTER 4: INFERIOR VENA CAVA FILTER MARKET

• Exhibit 106: IVCF Market, Europe (US$), 2007 - 2013
• Exhibit 107: IVCF Placements, by Country, Europe, 2007 - 2013
• Exhibit 108: IVCF Placements, by Device Type and Country, Europe, 2007 - 2013
• Exhibit 109: IVCF Placement Growth, by Device Type and Country, Europe, 2008 - 2013
• Exhibit 110: IVCF Retrievals, by Country, Europe, 2007 - 2013
• Exhibit 111: IVCF Market, by Country, Europe (US$), 2007 - 2013 (Graphical Format)
• Exhibit 112: IVCF Market, by Device Type, as a % of Total, Europe, 2007 - 2013
• Exhibit 113: IVCF Market, by Country, Europe (US$ and € ), 2007 - 2013
• Exhibit 114: IVCF Market, by Country, Europe (US$), 2007 - 2013 (Tabular Format)
• Exhibit 115: IVCF Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 116: IVCF Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 117: Retrievable IVCF Market, by Country, Europe (US$), 2007 - 2013
• Exhibit 118: Retrievable IVCF Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 119: Retrievable IVCF Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 120: Permanent IVCF Market, by Country, Europe (US$), 2007 - 2013
• Exhibit 121: Permanent IVCF Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 122: Permanent IVCF Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 123: Drivers of the IVCF Market, Europe
• Exhibit 124: Limiters of the IVCF Market, Europe
• Exhibit 125: Leading Competitors in the IVCF Market, by Country, as a % of Total, Europe, 2008
• Exhibit 126: Leading Competitors in the Retrievable IVCF Market, by Country, as a % of Total, Europe, 2008
• Exhibit 127: Leading Competitors in the Permanent IVCF Market, by Country, as a % of Total, Europe, 2008

CHAPTER 5: NEUROVASCULAR EMBOLECTOMY DEVICE MARKET

• Exhibit 128: Neurovascular Embolectomy Device Market, by Country, Europe (US$), 2007 - 2013 (Graphical Format)
• Exhibit 129: Neurovascular Embolectomies, by Country, Europe, 2007 - 2013 (Graphical Format)
• Exhibit 130: Neurovascular Embolectomies, by Country, Europe, 2007 - 2013 (Tabular Format)
• Exhibit 131: Neurovascular Embolectomy Device Market, by Country, Europe (US$), 2007 - 2013
• Exhibit 132: Neurovascular Embolectomy Device Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 133: Neurovascular Embolectomy Device Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 134: Drivers of the Neurovascular Embolectomy Device Market, Europe
• Exhibit 135: Limiters of the Neurovascular Embolectomy Device Market, Europe
• Exhibit 136: Leading Competitors in the Neurovascular Embolectomy Device Market, by Country, as a % of Total, Europe, 2008

APPENDIX B: SUPPLEMENTAL EXHIBITS

• Exhibit 137: Clot Management Device Market, by Country, Europe (US$), 2007 - 2013 (Detailed Format)
• Exhibit 138: Thrombectomy Device Market, by Device Type, as a % of Total, Europe, 2008 (Detailed Format)
• Exhibit 139: Thrombolytic Infusion Catheter Market, Europe (US$), 2007 - 2013 (Detailed Format)
• Exhibit 140: IVCF Placements, by Device Type, as a % of Total, Europe, 2007 - 2013 (Detailed Format)
• Exhibit 141: Neurovascular Embolectomy Device Market, Europe (US$), 2007 - 2013 (Detailed Format)

Related Reports